BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 17545588)

  • 1. A role for the Fas/FasL system in modulating genetic susceptibility to T-cell lymphoblastic lymphomas.
    Villa-Morales M; Santos J; Pérez-Gómez E; Quintanilla M; Fernández-Piqueras J
    Cancer Res; 2007 Jun; 67(11):5107-16. PubMed ID: 17545588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of the Fas-apoptosis-signalling pathway by functional polymorphisms at Fas, FasL and Fadd and their implication in T-cell lymphoblastic lymphoma susceptibility.
    Villa-Morales M; González-Gugel E; Shahbazi MN; Santos J; Fernández-Piqueras J
    Carcinogenesis; 2010 Dec; 31(12):2165-71. PubMed ID: 20889682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional Fas (Cd95/Apo-1) promoter polymorphisms in inbred mouse strains exhibiting different susceptibility to gamma-radiation-induced thymic lymphoma.
    Villa-Morales M; Santos J; Fernández-Piqueras J
    Oncogene; 2006 Mar; 25(14):2022-9. PubMed ID: 16301997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional polymorphisms in FAS and FASL contribute to increased apoptosis of tumor infiltration lymphocytes and risk of breast cancer.
    Zhang B; Sun T; Xue L; Han X; Zhang B; Lu N; Shi Y; Tan W; Zhou Y; Zhao D; Zhang X; Guo Y; Lin D
    Carcinogenesis; 2007 May; 28(5):1067-73. PubMed ID: 17183065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IFN-gamma regulates Fas ligand expression in human CD4+ T lymphocytes and controls their anti-mycobacterial cytotoxic functions.
    Boselli D; Losana G; Bernabei P; Bosisio D; Drysdale P; Kiessling R; Gaston JS; Lammas D; Casanova JL; Kumararatne DS; Novelli F
    Eur J Immunol; 2007 Aug; 37(8):2196-204. PubMed ID: 17595676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of Fas (CD95) and FasL (CD178) polymorphisms in liver transplant recipients.
    Marín LA; Muro M; Moya-Quiles MR; Miras M; Minguela A; Bermejo J; Sanchez-Bueno F; Parrilla P; Alvarez-López MR
    Tissue Antigens; 2006 Feb; 67(2):117-26. PubMed ID: 16441482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of FAS-1377, FAS-670, and FASL-844 polymorphisms in tumor onset, progression, and pigment phenotypes of Swedish patients with melanoma: a case-control analysis.
    Zhang H; Sun XF; Synnerstad I; Rosdahl I
    Cancer J; 2007; 13(4):233-7. PubMed ID: 17762757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Putative association of Fas and FasL gene polymorphisms with clinical outcomes of hepatitis B virus infection.
    Jung YJ; Kim YJ; Kim LH; Lee SO; Park BL; Shin HD; Lee HS
    Intervirology; 2007; 50(5):369-76. PubMed ID: 17938571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms of death pathway genes FAS and FASL and risk of premalignant gastric lesions.
    Hsu PI; Lu PJ; Wang EM; Ger LP; Lo GH; Tsay FW; Chen TA; Yang HB; Chen HC; Lin WS; Lai KH
    Anticancer Res; 2008; 28(1A):97-103. PubMed ID: 18383830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms in the FAS and FASL genes and survival of early stage non-small cell lung cancer.
    Park JY; Lee WK; Jung DK; Choi JE; Park TI; Lee EB; Cho S; Park JY; Cha SI; Kim CH; Kam S; Jung TH; Jheon S
    Clin Cancer Res; 2009 Mar; 15(5):1794-800. PubMed ID: 19240174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reciprocal co-expression of Fas and Fas ligand in human cholangiocarcinoma.
    Pan G; Ahn EY; Chen Y; Feng G; Reddy V; Jhala NC; McDonald JM
    Int J Oncol; 2007 Oct; 31(4):843-50. PubMed ID: 17786316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of dioxin response element and nuclear factor-kappaB motifs in 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated regulation of Fas and Fas ligand expression.
    Singh NP; Nagarkatti M; Nagarkatti PS
    Mol Pharmacol; 2007 Jan; 71(1):145-57. PubMed ID: 16940415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fas transduces dual apoptotic and trophic signals in hematopoietic progenitors.
    Pearl-Yafe M; Stein J; Yolcu ES; Farkas DL; Shirwan H; Yaniv I; Askenasy N
    Stem Cells; 2007 Dec; 25(12):3194-203. PubMed ID: 17872500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fas-1377A/G and FasL-844 T/C gene polymorphisms and epithelial ovarian cancer.
    Gormus U; Ergen A; Yilmaz H; Dalan B; Berkman S; Isbir T
    Anticancer Res; 2007; 27(2):991-4. PubMed ID: 17465232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional variants in cell death pathway genes and risk of pancreatic cancer.
    Yang M; Sun T; Wang L; Yu D; Zhang X; Miao X; Liu J; Zhao D; Li H; Tan W; Lin D
    Clin Cancer Res; 2008 May; 14(10):3230-6. PubMed ID: 18483392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fas 670 promoter polymorphism is associated to susceptibility, clinical presentation, and survival in adult T cell leukemia.
    Farre L; Bittencourt AL; Silva-Santos G; Almeida A; Silva AC; Decanine D; Soares GM; Alcantara LC; Van Dooren S; Galvão-Castro B; Vandamme AM; Van Weyenbergh J
    J Leukoc Biol; 2008 Jan; 83(1):220-2. PubMed ID: 17962369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Fas and Fas-ligand in donor hematopoietic stem and progenitor cells is dissociated from the sensitivity to apoptosis.
    Pearl-Yafe M; Yolcu ES; Stein J; Kaplan O; Shirwan H; Yaniv I; Askenasy N
    Exp Hematol; 2007 Oct; 35(10):1601-12. PubMed ID: 17889725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for stroma-derived annexin A1 as mediator in the control of genetic susceptibility to T-cell lymphoblastic malignancies through prostaglandin E2 secretion.
    Santos J; González-Sánchez L; Matabuena-Deyzaguirre M; Villa-Morales M; Cozar P; López-Nieva P; Fernández-Navarro P; Fresno M; Díaz-Muñoz MD; Guenet JL; Montagutelli X; Fernández-Piqueras J
    Cancer Res; 2009 Mar; 69(6):2577-87. PubMed ID: 19244132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ROS-mediated p38alpha MAPK activation and ERK inactivation responsible for upregulation of Fas and FasL and autocrine Fas-mediated cell death in Taiwan cobra phospholipase A(2)-treated U937 cells.
    Liu WH; Cheng YC; Chang LS
    J Cell Physiol; 2009 Jun; 219(3):642-51. PubMed ID: 19180563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pentoxifylline induces apoptosis in vitro in cutaneous T cell lymphoma (HuT-78) and enhances FasL mediated killing by upregulating Fas expression.
    Rishi L; Gahlot S; Kathania M; Majumdar S
    Biochem Pharmacol; 2009 Jan; 77(1):30-45. PubMed ID: 18851957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.